These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
5. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481 [TBL] [Abstract][Full Text] [Related]
6. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Winkelmayer WC; Waikar SS; Mogun H; Solomon DH Am J Med; 2008 Dec; 121(12):1092-8. PubMed ID: 19028206 [TBL] [Abstract][Full Text] [Related]
7. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect? Hudson M; Rahme E; Richard H; Pilote L Arthritis Rheum; 2007 Apr; 57(3):516-23. PubMed ID: 17394181 [TBL] [Abstract][Full Text] [Related]
8. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Patterson MK; Castellsague J; Walker AM Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817 [TBL] [Abstract][Full Text] [Related]
10. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235 [TBL] [Abstract][Full Text] [Related]
11. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rahme E; Nedjar H Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138 [TBL] [Abstract][Full Text] [Related]
12. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Andersohn F; Suissa S; Garbe E Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816 [TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365 [TBL] [Abstract][Full Text] [Related]
14. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with celecoxib and rofecoxib utilization. Rawson NS; Nourjah P; Grosser SC; Graham DJ Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF; Hsiao FY; Wen YW; Tsai YW Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [TBL] [Abstract][Full Text] [Related]
17. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related]
18. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines. Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959 [TBL] [Abstract][Full Text] [Related]
19. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study. Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471 [TBL] [Abstract][Full Text] [Related]
20. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]